Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTPγS binding

被引:25
作者
Geurts, M [1 ]
Hermans, E [1 ]
Maloteaux, JM [1 ]
机构
[1] Univ Catholique Louvain, Pharmacol Lab, FARL 5410, B-1200 Brussels, Belgium
关键词
S-35]GTP gamma S binding; spiperone; striatal membranes; G protein; D1 dopamine receptor; D2 dopamine receptor;
D O I
10.1016/S0024-3205(99)00412-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The dopamine receptor-mediated modulation of guanosine 5'-O-(gamma[S-35]thio)triphosphate ([S-35]GTP gamma S) binding has been characterized in rat striatal membranes. In optimized experimental conditions, the potency of dopamine was 4.47 mu M [3.02 - 6.61 mu M] and a maximal response representing 54.8 +/- 4.5 % increase above basal level was observed. Data obtained with different agonists and antagonists clearly revealed that the most important fraction of this response was reflecting D2 receptor activation. Further analysis with specific antagonists also supported evidence for the involvement of Dl dopamine receptors. The potencies of compounds interacting with D1 and D2 receptors were deduced from [S-35]GTP gamma S binding experiments and compared with their binding affinities for these receptors measured in similar experimental conditions. A good correlation between these parameters was observed, supporting the applicability of this technique for the study of dopamine receptors in the central nervous system.
引用
收藏
页码:1633 / 1645
页数:13
相关论文
共 50 条
[21]   IDENTIFICATION, CHARACTERIZATION, AND LOCALIZATION OF THE DOPAMINE-D3 RECEPTOR IN RAT-BRAIN USING 7-[H-3]HYDROXY-N,N-DI-NORMAL-PROPYL-2-AMINOTETRALIN [J].
LEVESQUE, D ;
DIAZ, J ;
PILON, C ;
MARTRES, MP ;
GIROS, B ;
SOUIL, E ;
SCHOTT, D ;
MORGAT, JL ;
SCHWARTZ, JC ;
SOKOLOFF, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8155-8159
[22]   LOCALIZATION OF D(1) AND D(2) DOPAMINE-RECEPTORS IN BRAIN WITH SUBTYPE-SPECIFIC ANTIBODIES [J].
LEVEY, AI ;
HERSCH, SM ;
RYE, DB ;
SUNAHARA, RK ;
NIZNIK, HB ;
KITT, CA ;
PRICE, DL ;
MAGGIO, R ;
BRANN, MR ;
CILIAX, BJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8861-8865
[23]  
LIEBERMAN AN, 1985, PHARMACOL REV, V37, P217
[24]  
LORENZEN A, 1993, MOL PHARMACOL, V44, P115
[25]  
Malmberg Å, 1998, J PHARMACOL EXP THER, V285, P119
[26]  
MARCOTTE ER, 1997, NEUROMETH, V31, P139
[27]   DOPAMINERGIC INHIBITION OF ADENYLATE-CYCLASE CORRELATES WITH HIGH-AFFINITY AGONIST BINDING TO ANTERIOR-PITUITARY D2-DOPAMINE RECEPTORS [J].
MCDONALD, WM ;
SIBLEY, DR ;
KILPATRICK, BF ;
CARON, MG .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1984, 36 (03) :201-209
[28]   THE SELECTIVITY OF SOME ERGOT DERIVATIVES FOR ALPHA-1-ADRENOCEPTORS AND ALPHA-2-ADRENOCEPTORS OF RAT CEREBRAL-CORTEX [J].
MCPHERSON, GA ;
BEART, PM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (04) :363-369
[29]   REPEATED ADMINISTRATION OF (-)SULPIRIDE AND SCH-23390 DIFFERENTIALLY UP-REGULATE D-1 AND D-2 DOPAMINE RECEPTOR FUNCTION IN RAT MESOSTRIATAL AREAS BUT NOT IN CORTICAL-LIMBIC BRAIN-REGIONS [J].
MEMO, M ;
PIZZI, M ;
NISOLI, E ;
MISSALE, C ;
CARRUBA, MO ;
SPANO, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 138 (01) :45-51
[30]  
Miyagi M, 1996, BIOL PHARM BULL, V19, P1210